Bridgebio Oncology Therapeutics Return on Net Operating Assets Analysis

Bridgebio Oncology Therapeutics, Inc. (BBOT)

9.98 -0.14 (-1.38%) USD | NASDAQ | Feb 20, 16:00

9.99 +0.01 (+0.10%) After-Hours: 20:00

View Return on Net Operating Assets for BBOT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Rapport Therapeutics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Agenus, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade